Announcements Trials
Browse Landscape

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 9Observational 2

Sponsor

Cancer Type

Gastrointestinal 4CNS 2Thoracic 1Breast 1

Conditions

Glioma 1Glioblastoma 1

Interventions

Magnetic Resonance Spectroscopy 24Surveys and Questionnaires 23Radiotherapy 23Blood Specimen Collection 20Radiosurgery 17Temozolomide 13Magnetic Resonance Imaging 12Surgical Procedures, Operative 10Neuropsychological Tests 10Radiation 8Polymerase Chain Reaction 8Immunohistochemistry 8Gene Expression Profiling 8Amplified Fragment Length Polymorphism Analysis 8Mental Status and Dementia Tests 6Phlebotomy 5Observation 5Flow Cytometry 5Watchful Waiting 4Quality of Life 4Psychiatric Rehabilitation 4Microarray Analysis 4Interviews as Topic 4Drug Therapy 4Biopsy 4vorasidenib 3gadobenic acid 3Transurethral Resection of Bladder 3Radiotherapy, Intensity-Modulated 3Physical Examination 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × apatinib × CNS × Clear all
NCT04216550 2021-02-08

Prediction of Therapeutic Response of Apatinib in Recurrent Gliomas

The First Affiliated Hospital of Zhengzhou University

Unknown
600 enrolled
CNS

Glioma

NCT03567135 2020-03-03

Temozolomide Plus Anti-angiogenesis Drugs and Radiotherapy as a Treatment for Glioblastoma

Fuzhou General Hospital

Unknown
60 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡